A multi-faceted reorganization of sickle cell disease (SCD) treatment at Yale New Haven Hospital led to dramatic drops in inpatient care, emergency department visits, and costs, and led to nearly two-thirds of patients reporting feeling better off as a result of the new treatment paradigm. The reorganization is outlined in an article in PLoS One. The report suggests that one drawback of the program was that even when patients felt more cared for, they were frustrated by what some saw as a lack of shared decision-making.
|